ICMA Photos / Flickr Creative Commons

Cigna still doesn't appear to be gung-ho about its proposed merger with Anthem. In a regulatory filing Thursday, Cigna said it will "evaluate its options" after a federal court rules on the merger, even though no decision has been made yet.

Anthem sent a written notice this week asking to extend the deal's deadline to April 30 as the two sides await to hear from a federal judge following a lengthy trial. The Department of Justice sued to block the deal, along with the Aetna-Humana transaction, arguing the health insurance mergers are anticompetitive. The filing is yet another sign of Cigna's lukewarm attitude.

Background: Anthem has pursued its $53 billion acquisition of Cigna since July 2015, and it's been messy from the start. David Cordani, Cigna's chief executive officer, wanted to be the future chief executive officer of the combined company, but was given no such assurances. The legal teams at Anthem and Cigna also have had a contentious relationship, as the Wall Street Journal has outlined.

Go deeper

Senate advances Amy Coney Barrett nomination, setting up final confirmation vote

Photo: Xinhua/Ting Shen via Getty Images

The Senate voted 51-48 on Sunday to advance the Supreme Court nomination of Judge Amy Coney Barrett, setting up a final confirmation vote for Monday.

Why it matters: It's now virtually inevitable that the Senate will vote to confirm President Trump's third Supreme Court nominee before the election, which is just nine days away.

Felix Salmon, author of Capital
2 hours ago - Economy & Business

Wall Street is living up to its bad reputation

Illustration: Sarah Grillo/Axios

Recent headlines will have you convinced that Wall Street is hell-bent on living up to all of its stereotypes.

Driving the news: Goldman Sachs is the biggest and the boldest, paying more than $5 billion in fines in the wake of the 1MDB scandal, in which billions were stolen from the people of Malaysia.

2 hours ago - Health

Ex-FDA chief: Pence campaigning after COVID exposure puts others at risk

Former FDA commissioner Scott Gottlieb said "the short answer is yes" when asked whether Vice President Mike Pence is putting others at risk by continuing to campaign after several aides tested positive for COVID-19, stressing that the White House needs to be "very explicit about the risks that they're taking."

Why it matters: The New York Times reports that at least five members of Pence's inner circle, including his chief of staff Marc Short and outside adviser Marty Obst, have tested positive for the virus. Pence tested negative on Sunday morning, according to the VP's office, and he'll continue to travel for the final stretch of the 2020 campaign.